Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Ambulatory pH Monitoring: New Advances and Indications.

Lutsi B, Hirano I.

Gastroenterol Hepatol (N Y). 2006 Nov;2(11):835-842.

2.

Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.

Roman S, Kahrilas PJ.

Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):17-28. doi: 10.1016/j.bpg.2014.11.002. Epub 2014 Nov 12. Review.

3.

Barrett esophagus in Asia: same disease with different pattern.

Lee HS, Jeon SW.

Clin Endosc. 2014 Jan;47(1):15-22. doi: 10.5946/ce.2014.47.1.15. Epub 2014 Jan 24. Review.

4.

Endocytoscopic visualization of squamous cell islands within Barrett's epithelium.

Eleftheriadis N, Inoue H, Ikeda H, Onimaru M, Yoshida A, Hosoya T, Maselli R, Kudo SE.

World J Gastrointest Endosc. 2013 Apr 16;5(4):174-9. doi: 10.4253/wjge.v5.i4.174.

5.

Natural history of Barrett's esophagus.

Milind R, Attwood SE.

World J Gastroenterol. 2012 Jul 21;18(27):3483-91. doi: 10.3748/wjg.v18.i27.3483. Review.

6.

Barrett's esophagus with high-grade dysplasia: focus on current treatment options.

Lekakos L, Karidis NP, Dimitroulis D, Tsigris C, Kouraklis G, Nikiteas N.

World J Gastroenterol. 2011 Oct 7;17(37):4174-83. doi: 10.3748/wjg.v17.i37.4174. Review.

7.

Proximal and distal esophageal sensitivity is decreased in patients with Barrett's esophagus.

Krarup AL, Olesen SS, Funch-Jensen P, Gregersen H, Drewes AM.

World J Gastroenterol. 2011 Jan 28;17(4):514-21. doi: 10.3748/wjg.v17.i4.514.

8.

Pathophysiology and treatment of Barrett's esophagus.

Oh DS, Demeester SR.

World J Gastroenterol. 2010 Aug 14;16(30):3762-72. Review.

9.

Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis.

Akiyama T, Inamori M, Iida H, Endo H, Hosono K, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Koide T, Tokoro C, Goto A, Abe Y, Shimamura T, Kobayashi N, Kubota K, Saito S, Nakajima A.

World J Gastroenterol. 2010 Jan 28;16(4):484-9.

10.

Antireflux surgery, barrett esophagus, and adenocarcinoma: there is still room for doubt.

Jamieson GG.

Ann Surg. 2007 Jul;246(1):22-3. No abstract available.

11.

Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.

Williams LJ, Guernsey DL, Casson AG.

Curr Oncol. 2006 Feb;13(1):33-43.

12.

Barrett's oesophagus: from metaplasia to dysplasia and cancer.

Fléjou JF.

Gut. 2005 Mar;54 Suppl 1:i6-12. Review.

13.

Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy.

Wolfsen HC, Hemminger LL, DeVault KR.

BMC Gastroenterol. 2004 Aug 25;4:18.

14.

Symptoms, acid exposure and motility in patients with Barrett's esophagus.

Brandt MG, Darling GE, Miller L.

Can J Surg. 2004 Feb;47(1):47-51.

15.

Effect of body mass index on adenocarcinoma of gastric cardia.

Zhang J, Su XQ, Wu XJ, Liu YH, Wang H, Zong XN, Wang Y, Ji JF.

World J Gastroenterol. 2003 Dec;9(12):2658-61.

16.

Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery.

Oelschlager BK, Barreca M, Chang L, Oleynikov D, Pellegrini CA.

Ann Surg. 2003 Oct;238(4):458-64; discussion 464-6.

17.

Oesophageal pH monitoring in Barrett's oesophagus.

Neumann CS, Cooper BT.

Gut. 2003 Jan;52(1):153; author reply 153-4. No abstract available.

18.

Metaplastic columnar mucosa in the cervical esophagus after esophagectomy.

Oberg S, Johansson J, Wenner J, Walther B.

Ann Surg. 2002 Mar;235(3):338-45.

19.

Correlation of oesophageal acid exposure with Barrett's oesophagus length.

Fass R, Hell RW, Garewal HS, Martinez P, Pulliam G, Wendel C, Sampliner RE.

Gut. 2001 Mar;48(3):310-3.

20.

Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy.

DeMeester SR, DeMeester TR.

Ann Surg. 2000 Mar;231(3):303-21. Review.

Supplemental Content

Support Center